(Opinion Article) Pathway to Privacy: Time to Take Ownership of Re-building Trust with Patients

FairWarningBy Tim Dunn, General Manager, FairWarning.
The government has finally published its long-awaited response to the Caldicott2 review of information sharing in the NHS - and, as many of us had hoped, has accepted all of its recommendations. It's a landmark moment that could see the NHS turn an important corner and stride progressively towards building transformational models of care.

After years of analysis and consultation about the merits of electronic healthcare, the time for debate is over.

There are key elements within Caldicott2 I believe will be essential in assuring the confidence and trust of patients and healthcare professionals, they include: the duty of candor and notification of data breaches, how they happened and what remediation steps are being taken; a patient's right to know of "everyone and anyone" who has accessed their record; a robust audit and enforcement framework agreed between the Information Commissioners Office (ICO) and Care Quality Commission (CQC) and electronic health records (HER) vendors supporting audit and logs on access activity.

The Government response reaffirms the belief that better information sharing can help the NHS meet many of its strategic goals, and lead to more effective and efficient healthcare services, enhanced care pathways and improved patient outcomes. But a critical success factor for sharing health information will be ensuring that it is done in such a way that it reassures patients that their privacy will be protected.

The Caldicott2 recommendation that patients should have availability to 'details on everyone and anyone who has accessed their record', along with the requirement 'to notify patients when their records have been breached', represents a huge step towards transparent healthcare. But to deliver it, the NHS needs to foster a culture of collective responsibility for patient privacy, and drive accountability across local organisations.

At a local level, ownership for driving change and leading NHS organisations towards secure electronic healthcare largely rests with a triumvirate of key stakeholders; CEOs, Senior Information Risk Officers (SIRO) and Caldicott Guardians.

Responsibilities
As trusts grapple with strategic challenges to ensure they are financially robust and competitive within the new commissioning environment, hospitals are increasingly recognising the role that digital healthcare can play in meeting their objectives. As a result, the development of EHR systems, in line with the government timetable for electronic patient records, has become a major priority. Although the CEO is ultimately accountable for data control on behalf of a trust, responsibility for overall ownership of the organisation's Information Risk Policy is delegated to the SIRO.

SIROs have been in existence within trusts for a number of years, but the significance of the role has been reinforced by the Department of Health (DH) response to Caldicott2. The function, performed in addition to individuals' existing NHS roles, is defined as an Executive Director or Senior Management Board member who is formally responsible for the organisation's standards of practice for information governance.

The SIRO acts as the Board's 'champion' for information risk, advising the CEO on the organisation's information governance strategy and capabilities. As a prominent board member, the SIRO is naturally familiar with a trust's wider strategic goals. But the challenge is to understand how those goals may be impacted by information risks and how, in turn, those risks should be managed.

The SIRO's key purpose is to lead and implement Information Governance risk assessment and management processes, and provide assurance to the CEO and board of the effectiveness of the trust's information risk management. It is a significant responsibility and, since trusts commonly have high volumes of information assets, is not something that can be managed alone. The SIRO must work collaboratively with internal and external stakeholders to reinforce a culture of privacy and drive accountability and responsibility across an NHS organisation.

Alongside SIROs, Caldicott Guardians are also growing in influence. Originally introduced to provide trust boards with advice on how patient information should be shared - acting as the 'conscience of the organisation' - the Caldicott Guardian’s role is now being extended to take a greater lead on information governance, Its primary purposes are to ensure information governance is effective and to provide oversight of information sharing amongst clinicians.

But distinct from SIROs - whose remit is to look at risks across all information systems - Caldicott Guardians are solely focused on patient identifiable information. Their rationale is to safeguard and govern uses of patient information within a trust, as well as data flows to other NHS and non-NHS organisations.

In this context, there is now the opportunity and indeed the expectation that Caldicott Guardians will take ownership of the implementation of Caldicott2 for their organisation and, as a fellow board member, they must work closely with the SIRO to ensure a trust's information risk strategy protects patient confidentiality.

Where next?
So armed with a robust framework to underpin the secure and effective implementation of information sharing, how can NHS organisations make the move from ideology to delivery? Trusts that make the greatest strides towards protecting patient confidentiality will be those where the SIRO and the Caldicott Guardian work closely together.

Best practice examples show that the most proactive trusts have embraced the need to ensure organisation-wide understanding of the importance of data sharing and patient confidentiality - and, championed by both SIROs and Caldicott Guardians, have facilitated sustained engagement with Information Asset Owners and trust staff to develop a culture of privacy.

The effective use of technology has also proved a critical success factor. The requirement to report privacy breaches has placed SIROs under increased pressure to ensure trusts are maintaining the highest standards of information governance - indeed DH training for SIROs states that any privacy breach could be a 'career-ending event'. But innovative solutions are there to support them.

Technology is readily available that can provide increased transparency regarding who is accessing patient records and enable trusts to monitor access proactively. In fact, the government's response to Caldicott2 highlighted the effective use of privacy breach detection tools (or patient privacy monitoring solutions as they are often called) in NHS Scotland as a good example of best practice.

Use of such technology can significantly help SIROs underpin their responsibilities for information assurance and, in the process, facilitate the optimal use of patient data to support the strategic goals outlined by the CEO and board. Patient privacy monitoring solutions provide SIROs with greater assurance that data access is appropriate and can protect a trust’s reputation by mitigating the risk of confidentiality breaches. Furthermore, the use of technology can help trusts reinforce a culture of privacy.

Caldicott2 represents a significant milestone in the UK's ambitions to harness the power of information. To seize the opportunity, SIROs should redouble their efforts to drive collective responsibility across the organisation, and set up an appropriate information risk framework that focuses the trust on the importance of data transparency. And, as an increasing number of UK trusts are beginning to do, they should consider putting in place the appropriate technology that underpins the Caldicott2 recommendations.

The secure, timely and effective sharing of patient information can transform healthcare services in the UK. But it will only succeed if patients' personal data is treated with propriety and respect. As Jeremy Hunt said in his endorsement of the Caldicott2 recommendations, "the prize for achieving this is very great indeed."

About FairWarning, Inc.
FairWarning empowering care providers to grow their reputation for protecting confidentiality, scale their digital health initiatives and comply with complex privacy laws. By partnering with FairWarning, care providers are able to direct their focus on delivering the best patient outcomes possible while receiving expert, sustainable and affordable privacy and compliance solutions. Customers consider FairWarning such as ARRA HITECH privacy and meaningful use criteria, HIPAA, UK and EU Data Protection, and Canadian provincial healthcare privacy law.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...